Amgen announced that the U.S. Food and Drug Administration has completed its review of the company’s supplemental New Drug Application seeking full approval of LUMAKRAS®.
Amgen announced that the U.S. Food and Drug Administration has completed its review of the company’s supplemental New Drug Application seeking full approval of LUMAKRAS®.